ATP1A3 Gene Alternating hemiplegia of childhood type 2 Genetic Test sale cost 4400 AED
DHH Gene 46XY gonadal dysgenesis partial with minifascicular neuropathy Genetic Test sale cost 4400 AED DHH Gene 46XY gonadal dysgenesis partial with minifascicular neuropathy Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ST3GAL5 Gene Amish infantile epilepsy syndrome Genetic Test sale cost 4400 AED ST3GAL5 Gene Amish infantile epilepsy syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ATP1A3 Gene Alternating hemiplegia of childhood type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATP1A3 gene is implicated in a rare neurological disorder known as Alternating Hemiplegia of Childhood type 2 (AHC2). This condition is characterized by recurrent episodes of paralysis that affects either side of the body, dystonia, developmental delay, and seizures. The ATP1A3 gene encodes a subunit of the Na+/K+ ATPase pump, crucial for maintaining the electrochemical gradient across the cell membrane, which is essential for normal brain function.

DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the ATP1A3 gene, which can confirm a diagnosis of AHC2. This test is particularly important for families seeking a definitive diagnosis and for guiding treatment plans. The cost of the test is 4400 AED. Early diagnosis through genetic testing can lead to better management of the symptoms and improve the quality of life for individuals affected by this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 Genetic Test

At DNA Labs UAE, we offer the ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 Genetic Test. This test helps diagnose individuals with Alternating Hemiplegia of Childhood (AHC) type 2, a rare neurological disorder characterized by recurrent episodes of paralysis affecting one side of the body or the other.

Test Components

  • Price: 4400.0 AED

Sample Condition

We accept blood samples, extracted DNA, or one drop of blood on FTA Card for this test.

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Method

We use NGS (Next-Generation Sequencing) technology for this genetic test.

Test Type

This test is specifically designed for diagnosing neurological disorders.

Doctor

The test is performed under the supervision of a Neurologist.

Test Department

This test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 NGS Genetic DNA Test, it is essential to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2.

Test Details

Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that typically develops in early childhood. It is characterized by recurrent episodes of paralysis affecting one side of the body or the other. AHC is caused by mutations in the ATP1A3 gene, which provides instructions for making a protein essential for the proper functioning of nerve cells.

Our NGS genetic testing utilizes advanced technology to analyze multiple genes simultaneously. By conducting an NGS genetic test for the ATP1A3 gene, we can identify mutations associated with AHC type 2, which is a specific subtype of AHC.

If an individual is suspected of having AHC or has a family history of the disorder, they may be suitable candidates for NGS genetic testing. The results from this test can provide a definitive diagnosis and assist in guiding treatment and management strategies.

Test Name ATP1A3 Gene Alternating hemiplegia of childhood type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATP1A3 Gene Alternating hemiplegia of childhood type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP1A3 Gene Alternating hemiplegia of childhood type 2
Test Details

Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that typically develops in early childhood and is characterized by recurrent episodes of paralysis affecting one side of the body or the other. AHC is caused by mutations in the ATP1A3 gene, which provides instructions for making a protein that is essential for the proper functioning of nerve cells.

NGS (next-generation sequencing) genetic testing is a type of genetic testing that allows for the rapid and comprehensive analysis of multiple genes simultaneously. A NGS genetic test for the ATP1A3 gene can identify mutations that are associated with AHC type 2, which is a specific subtype of AHC.

Individuals who are suspected of having AHC or who have a family history of the disorder may be candidates for NGS genetic testing. Results from the test can provide a definitive diagnosis and may help guide treatment and management strategies.

SKU: TEST-1030 Category:

Related products